March 11, 2020
Artificial Intelligence Shows Disparities in White and Black Prostate Cancer Patients
According to The Daily, Case Western Reserve University researchers revealed cellular distinctions between black and white patients with prostate cancer, using artificial intelligence. The team reported in a recent study that AI analysis of digitized images of cancer tissues show critical variations between black and white male prostate cancer patients. The findings indicate that the...
Michael J. Fox Foundation Trial Finder Helps Recruit For Clinical Trials
According to ParkinsonNewsToday.com, the Michael J. Fox Foundation for Parkinson’s Research (MJFF) revamped the Fox Trial Finder, a tool that matches Parkinson’s patients and healthy volunteers with clinical trial studies. “At the Foundation, our single urgent goal is to eliminate Parkinson’s disease,” Sohini Chowdhury, MJFF’s deputy CEO, said in a press release. “It will take...
Health Influencers Can Help Dramatically Increase Clinical Trial Recruitment Reach
Per a study by Leapcure, a tech-focused clinical trial organization, recruiting with health influencers more than doubles the reach to patients. The company launched a pilot program in 2019 that measured how effective health influencers are to recruitment. It concluded that tapping health influencers costs significantly less than traditional advertising methods but packs a way...
Statins Alone, with Metformin Bring Positive Results for High-Risk Prostate Cancer Patients
A retrospective study recently published in Cancer Medicine states that use of statins as monotherapy or with metformin is linked with lower mortality among men with high-risk prostate cancer. “Both metformin and statins have been associated with longer life [among men with] prostate cancer, yet because they are commonly prescribed together, no study we know...
Clinical Assessment of PAD on the Primary Care Spectrum
By the year 2050 over 19 million will have Peripheral Arterial Disease. Watch this webinar from the American Heart Association on the clinical assessment of PAD presented by Dr. Eileen Walsh from the College of Nursing at the University of Toledo.
Improving Awareness of Peripheral Artery Disease
Peripheral artery disease (PAD) is a progressive atherosclerotic disease in which one or more peripheral arteries, typically in the lower limbs, are partially or completely obstructed, reducing blood perfusion to the limb. Overall, PAD affects approximately 8.5 million Americans, most of them age 65 and older. A recent analysis of Medicare inpatient and outpatient claims...